Cargando…
MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
BACKGROUND: The average five-year survival for non-small cell lung cancer (NSCLC) patients is approximately 15%. Emerging evidence indicates that microRNAs (miRNAs) constitute a new class of gene regulators in humans that may play an important role in tumorigenesis. Hence, there is growing interest...
Autores principales: | Gallach, Sandra, Jantus-Lewintre, Eloisa, Calabuig-Fariñas, Silvia, Montaner, David, Alonso, Sergio, Sirera, Rafael, Blasco, Ana, Usó, Marta, Guijarro, Ricardo, Martorell, Miguel, Camps, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593550/ https://www.ncbi.nlm.nih.gov/pubmed/28915579 http://dx.doi.org/10.18632/oncotarget.18603 |
Ejemplares similares
-
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014) -
Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients
por: Dong, Ning, et al.
Publicado: (2021) -
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
por: Usó, Marta, et al.
Publicado: (2016) -
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2019) -
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
por: Moreno-Manuel, Andrea, et al.
Publicado: (2020)